InsidersTradesSigma
Track the 비씨월드제약 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 비씨월드제약 has recorded 6 public disclosures. Market capitalisation: €31.4bn. The latest transaction was filed on 14 April 2026 (Purchase). Among the most active insiders: 홍성한. The full history is openly available.
5
Insider Decl.
n/a
Thresholds
€875,106
5 ops.
Buy Volume
n/a
n/a
Sell Volume
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,111 of 29,062 companies
38.9
score / 100
Value42
Quality36
FCF yld4.9%
Earn yld-15%
EV/EBITDA11.9x
ROE9.8%
Gross mgn40%
Net mgn-6.5%
Debt/EBITDA8.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 14 April 2026
Declarations6 total
Other
6 of 6 declarations
Acerca de 비씨월드제약
BC World Pharma es una empresa del sector sanitario y farmacéutico que cotiza en el mercado XKRX. Se especializa en el desarrollo y la comercialización de productos farmacéuticos.